Cambridge Investment Research Advisors’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,175
| Closed | -$73K | – | 3398 |
|
|
2024
Q1 | $73K | Sell |
15,175
-4,057
| -21% | -$19.5K | ﹤0.01% | 3182 |
|
|
2023
Q4 | $92K | Sell |
19,232
-9,996
| -34% | -$47.8K | ﹤0.01% | 3048 |
|
|
2023
Q3 | $212K | Buy |
+29,228
| New | +$212K | ﹤0.01% | 2769 |
|
|
2023
Q2 | – | Sell |
-12,432
| Closed | -$86K | – | 3256 |
|
|
2023
Q1 | $86K | Buy |
+12,432
| New | +$86K | ﹤0.01% | 2981 |
|
|
2022
Q4 | – | Sell |
-10,294
| Closed | -$187K | – | 3182 |
|
|
2022
Q3 | $187K | Sell |
10,294
-8,419
| -45% | -$153K | ﹤0.01% | 2720 |
|
|
2022
Q2 | $962K | Buy |
18,713
+4,272
| +30% | +$220K | 0.01% | 1505 |
|
|
2022
Q1 | $1.06M | Buy |
14,441
+2,609
| +22% | +$192K | ﹤0.01% | 1537 |
|
|
2021
Q4 | $1.69M | Buy |
11,832
+3,313
| +39% | +$474K | 0.01% | 1242 |
|
|
2021
Q3 | $1.77M | Buy |
8,519
+613
| +8% | +$127K | 0.01% | 1166 |
|
|
2021
Q2 | $1.68M | Buy |
7,906
+1,845
| +30% | +$392K | 0.01% | 1212 |
|
|
2021
Q1 | $1.1M | Sell |
6,061
-3,305
| -35% | -$599K | 0.01% | 1373 |
|
|
2020
Q4 | $1.04M | Sell |
9,366
-980
| -9% | -$109K | 0.01% | 1279 |
|
|
2020
Q3 | $1.12M | Buy |
10,346
+2,766
| +36% | +$300K | 0.01% | 1121 |
|
|
2020
Q2 | $632K | Buy |
+7,580
| New | +$632K | ﹤0.01% | 1417 |
|
|
2019
Q2 | – | Sell |
-878
| Closed | -$10K | – | 2302 |
|
|
2019
Q1 | $10K | Sell |
878
-185
| -17% | -$2.11K | ﹤0.01% | 2267 |
|
|
2018
Q4 | $39K | Buy |
1,063
+199
| +23% | +$7.3K | ﹤0.01% | 2100 |
|
|
2018
Q3 | $32K | Buy |
864
+53
| +7% | +$1.96K | ﹤0.01% | 2212 |
|
|
2018
Q2 | $22K | Buy |
811
+27
| +3% | +$732 | ﹤0.01% | 2189 |
|
|
2018
Q1 | $33K | Buy |
+784
| New | +$33K | ﹤0.01% | 2115 |
|